Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries OptimizeRx Corporation - Common Stock (NQ: OPRX ) 6.710 +0.110 (+1.67%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about OptimizeRx Corporation - Common Stock < Previous 1 2 3 4 5 Next > OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value September 10, 2024 From OptimizeRx Corporation Via GlobeNewswire OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences September 09, 2024 From OptimizeRx Corporation Via GlobeNewswire A Closer Look at 5 Analyst Recommendations For OptimizeRx August 12, 2024 Via Benzinga Critical Insights From OptimizeRx Analyst Ratings: What You Need To Know June 21, 2024 Via Benzinga Expert Ratings For OptimizeRx May 15, 2024 Via Benzinga Where OptimizeRx Stands With Analysts April 01, 2024 Via Benzinga OPRX Stock Earnings: OptimizeRx Beats Revenue for Q4 2023 March 28, 2024 OPRX stock results show that OptimizeRx beat on revenue for the fourth quarter of 2023. Via InvestorPlace OPRX Stock Earnings: OptimizeRx Beats EPS, Misses Revenue for Q2 2024 August 08, 2024 OPRX stock results show that OptimizeRx beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. Via InvestorPlace OptimizeRx Reports Second Quarter 2024 Financial Results August 08, 2024 From OptimizeRx Corporation Via GlobeNewswire OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET July 25, 2024 From OptimizeRx Corporation Via GlobeNewswire OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation July 23, 2024 OptimizeRx Micro Neighborhood® Targeting enables pharmaceutical brands to maintain and expand campaign scale nationwide From OptimizeRx Corporation Via GlobeNewswire OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients July 15, 2024 The Company’s AI-guided predictive targeting platform delivered three times the return in half the time of the traditional trigger-based program From OptimizeRx Corporation Via GlobeNewswire New White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Value to Clinical Conversations June 20, 2024 From OptimizeRx Corporation Via GlobeNewswire Gold Rises Over 1%; Arcos Dorados Shares Fall After Q1 Results May 15, 2024 Via Benzinga OptimizeRx Earnings Preview March 27, 2024 Via Benzinga Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session May 15, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session May 15, 2024 Via Benzinga Nasdaq Surges 150 Points; Retail Sales Flat For April May 15, 2024 Via Benzinga OPRX Stock Earnings: OptimizeRx Beats EPS, Beats Revenue for Q1 2024 May 14, 2024 OPRX stock results show that OptimizeRx beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's After-Market Session May 14, 2024 Via Benzinga OptimizeRx Reports First Quarter 2024 Financial Results May 14, 2024 From OptimizeRx Corporation Via GlobeNewswire OptimizeRx to Participate in Upcoming Investor Conferences May 06, 2024 From OptimizeRx Corporation Via GlobeNewswire OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET April 26, 2024 From OptimizeRx Corporation Via GlobeNewswire OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report April 18, 2024 From OptimizeRx Corporation Via GlobeNewswire OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results April 16, 2024 From OptimizeRx Corporation Via GlobeNewswire OptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Row April 11, 2024 Market Embraces Disruptive AI-Powered Capabilities From OptimizeRx Corporation Via GlobeNewswire 7 Top Undervalued Stocks Primed for a Multibagger Recovery April 06, 2024 These seven undervalued stocks are trading at discounted prices but have the potential to deliver multibagger returns in the coming years. Via InvestorPlace OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET March 25, 2024 From OptimizeRx Corporation Via GlobeNewswire Earnings Scheduled For March 28, 2024 March 28, 2024 Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million. Via Benzinga OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023 March 11, 2024 From OptimizeRx Corporation Via GlobeNewswire < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.